Title:
ヒスタミンH3受容体薬剤、製剤及び治療的使用
Document Type and Number:
Japanese Patent JP5193033
Kind Code:
B2
Abstract:
The present invention discloses novel compounds of Formula I or pharmaceutically acceptable salts thereof which have histamine-H3 receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula I as well as methods of using them to treat obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor-related diseases.
Inventors:
Lisa Selsom Beavers
Don Richard Finley
Robert Alan Gadsky
Philip Arthur Hipskind
William Joseph Hornback
Cynthia Darcini Jessdason
Richard Todd Picard
High Mulberry Takako
Grant Matthews Boat
Don Richard Finley
Robert Alan Gadsky
Philip Arthur Hipskind
William Joseph Hornback
Cynthia Darcini Jessdason
Richard Todd Picard
High Mulberry Takako
Grant Matthews Boat
Application Number:
JP2008519550A
Publication Date:
May 08, 2013
Filing Date:
June 28, 2006
Export Citation:
Assignee:
Eli Lilly and Company
International Classes:
C07D207/09; A61K31/4025; A61K31/454; A61K31/5377; A61P3/04; A61P25/28; C07D207/48
Domestic Patent References:
| JP2004532834A |
Foreign References:
| WO2003064411A1 | ||||
| WO2004037257A1 |
Attorney, Agent or Firm:
Kyousei Tamura
Samejima Mutsumi
Masahiro Nitta
Kure Hidenori
Nobuhiko Akiyama
Samejima Mutsumi
Masahiro Nitta
Kure Hidenori
Nobuhiko Akiyama